The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 09, 2020
Filed:
Mar. 04, 2016
Applicant:
Grünenthal Gmbh, Aachen, DE;
Inventors:
Elisabeth Arkenau-Marić, Köln, DE;
Johannes Bartholomäus, Aachen, DE;
Heinrich Kugelmann, Aachen, DE;
Assignee:
GRÜNENTHAL GMBH, Aachen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/485 (2006.01); B29C 48/00 (2019.01); B29C 48/21 (2019.01); B29C 48/14 (2019.01); A61K 31/135 (2006.01); A61K 31/277 (2006.01); A61K 31/4418 (2006.01); A61K 31/55 (2006.01); A61K 31/554 (2006.01); A61J 3/00 (2006.01); A61K 9/48 (2006.01); A61J 3/10 (2006.01); A61K 9/28 (2006.01); A61K 31/4422 (2006.01); B29B 7/00 (2006.01); B29B 9/02 (2006.01); B29B 9/12 (2006.01); B29C 43/02 (2006.01); A61J 3/06 (2006.01); A61K 9/00 (2006.01); B29K 105/00 (2006.01); B29C 35/02 (2006.01); B29C 45/00 (2006.01); B29L 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61J 3/005 (2013.01); A61J 3/06 (2013.01); A61J 3/10 (2013.01); A61K 9/205 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/2068 (2013.01); A61K 9/2072 (2013.01); A61K 9/2086 (2013.01); A61K 9/2095 (2013.01); A61K 9/2893 (2013.01); A61K 9/4808 (2013.01); A61K 31/135 (2013.01); A61K 31/277 (2013.01); A61K 31/4418 (2013.01); A61K 31/4422 (2013.01); A61K 31/55 (2013.01); A61K 31/554 (2013.01); B29B 7/002 (2013.01); B29B 9/02 (2013.01); B29B 9/12 (2013.01); B29C 43/02 (2013.01); B29C 48/0011 (2019.02); B29C 48/0022 (2019.02); B29C 48/022 (2019.02); B29C 48/146 (2019.02); B29C 48/21 (2019.02); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); B29C 35/0261 (2013.01); B29C 45/0001 (2013.01); B29C 2793/009 (2013.01); B29K 2105/0035 (2013.01); B29K 2105/0044 (2013.01); B29K 2105/251 (2013.01); B29K 2995/0056 (2013.01); B29L 2031/753 (2013.01); B29L 2031/772 (2013.01);
Abstract
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary substances (B) and optionally a synthetic, semi-synthetic or natural wax (D), wherein the dosage form exhibits a resistance to crushing of at least 400 N and wherein under physiological conditions the release of the physiologically active substance (A) from the dosage form is at least partially delayed.